​

Tango Therapeutics Ownership | Who Owns Tango Therapeutics?

OverviewForecastRevenueFinancialsChart

Tango Therapeutics Ownership Summary

Tango Therapeutics is owned by 17.57% institutional investors, 1.38% insiders, and 81.04% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 11.45% of TNGX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.73% of its assets in Tango Therapeutics shares.

TNGX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTango Therapeutics17.57%1.38%81.04%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp13.30M11.45%$278.25M
Adage capital partners gp12.81M11.03%$267.97M
Ecor1 capital10.63M9.62%$89.30M
Boxer capital management10.88M9.36%$227.53M
Tcg crossover management10.53M9.07%$220.31M
Fmr9.91M8.53%$207.23M
Farallon capital management9.10M7.83%$190.32M
Boxer capital8.20M7.58%$70.34M
Blackrock funding, inc. /de8.75M7.53%$183.01M
Woodline partners lp8.00M6.89%$167.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Trv gp iv6.37M49.96%$133.36M
Boxer capital management10.88M29.87%$227.53M
Nextech invest7.27M10.70%$152.01M
Acuta capital partners441.83K6.52%$9.24M
Tcg crossover management10.53M6.30%$220.31M
Ecor1 capital10.63M4.29%$89.30M
Vivo capital2.15M3.76%$45.08M
Boxer capital8.20M3.70%$70.34M
Caligan partners lp2.41M3.35%$50.39M
Siren5.66M3.28%$118.35M

Top Buyers

HolderShares% AssetsChange
Rtw investments, lp13.30M2.77%11.81M
Fmr9.91M0.01%7.04M
Paradigm biocapital advisors lp4.01M1.71%4.01M
Holocene advisors, lp3.93M0.20%3.93M
Adage capital partners gp12.81M0.41%2.20M

Top Sellers

HolderShares% AssetsChange
Southpoint capital advisors lp---5.00M
Gilead sciences---4.85M
Farallon capital management9.10M1.08%-3.96M
Suvretta capital management---2.66M
Siren5.66M3.28%-2.51M

New Positions

HolderShares% AssetsChangeValue
Holocene advisors, lp3.93M0.20%3.93M$82.27M
Cormorant asset management, lp1.43M1.50%1.43M$29.81M
Vanguard fiduciary trust662.92K0.00%662.92K$13.87M
Avoro capital advisors545.00K0.06%545.00K$4.58M
Ameriprise financial506.16K0.00%506.16K$10.59M

Sold Out

HolderChange
Srs capital advisors-8.00
Nelson, van denburg & campbell wealth management group-12.00
True wealth design-16.00
Versant capital management-28.00
Flagship harbor advisors-300.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202674-56.73%20,414,054-88.16%170.07%46-64.06%19-29.63%
Dec 31, 2025103-28.97%65,776,312-53.01%590.37%79-8.14%13-61.76%
Sep 30, 202514117.50%131,410,6723.26%1180.90%8421.74%3317.86%
Jun 30, 2025118-127,240,30347.81%1151.89%6715.52%28-28.21%
Mar 31, 2025121-11.68%107,289,0950.80%971.01%59-28.92%3840.74%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.94M2.73%10.45K
iShares Russell 2000 ETF2.62M1.81%22.04K
Fidelity Select Biotechnology2.53M1.75%1.94M
Fidelity Growth Compy Commingled Pl O1.69M1.58%-
State Street® SPDR® S&P® Biotech ETF2.20M1.52%-21.75K
Fidelity Growth Compy Commingled Pl S2.17M1.50%2.17M
T. Rowe Price Small-Cap Value1.54M1.39%-117.06K
Fidelity Growth Company Fund1.74M1.21%1.74M
Fidelity Small Cap Growth1.25M1.17%-
T. Rowe Price Small-Cap Stock1.19M1.11%199.50K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 01, 2026Crystal Adam President, R&DSell$136.63K
Jun 01, 2026Crystal Adam President, R&DSell$480.94K
May 01, 2026Crystal Adam President, R&DSell$24.20K
May 01, 2026Crystal Adam President, R&DSell$548.90K
Apr 15, 2026Crystal Adam President, R&DSell$961.50K

Insider Transactions Trends

DateBuySell
2026 Q2-2
2026 Q1-9
2025 Q4-1
2025 Q3-6
2025 Q2--

TNGX Ownership FAQ

Who Owns Tango Therapeutics?

Tango Therapeutics shareholders are primarily institutional investors at 17.57%, followed by 1.38% insiders and 81.05% retail investors. The average institutional ownership in Tango Therapeutics's industry, Biotech Stocks , is 35.75%, which Tango Therapeutics falls below.

Who owns the most shares of Tango Therapeutics?

Tango Therapeutics’s largest shareholders are Rtw investments, lp (13.3M shares, 11.45%), Adage capital partners gp (12.81M shares, 11.03%), and Ecor1 capital (10.63M shares, 9.62%). Together, they hold 32.09% of Tango Therapeutics’s total shares outstanding.

Does Blackrock own Tango Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tango Therapeutics.

Who is Tango Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Tango Therapeutics’s biggest shareholder by percentage of total assets invested, with 49.96% of its assets in 6.37M Tango Therapeutics shares, valued at 133.36M$.

Who is the top mutual fund holder of Tango Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tango Therapeutics shares, with 2.73% of its total shares outstanding invested in 3.94M Tango Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools